These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 26853324)

  • 1. Stimuli-responsive Smart Liposomes in Cancer Targeting.
    Jain A; Jain SK
    Curr Drug Targets; 2018 Feb; 19(3):259-270. PubMed ID: 26853324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Tumor Targeted Liposomes.
    Jain A; Jain
    Curr Mol Med; 2018; 18(1):44-57. PubMed ID: 29663884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional Liposomes.
    Aryasomayajula B; Salzano G; Torchilin VP
    Methods Mol Biol; 2017; 1530():41-61. PubMed ID: 28150195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
    Tavano L; Muzzalupo R
    Colloids Surf B Biointerfaces; 2016 Nov; 147():161-171. PubMed ID: 27500359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
    Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
    J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
    Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
    Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives.
    El-Sawy HS; Al-Abd AM; Ahmed TA; El-Say KM; Torchilin VP
    ACS Nano; 2018 Nov; 12(11):10636-10664. PubMed ID: 30335963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
    Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
    Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
    Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
    Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimuli-responsive polymers for anti-cancer drug delivery.
    Cheng W; Gu L; Ren W; Liu Y
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():600-8. PubMed ID: 25491870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive Carriers for Controlled Intracellular Drug Release.
    Sheng Y; Hu J; Shi J; Lee LJ
    Curr Med Chem; 2019; 26(13):2377-2388. PubMed ID: 28875840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
    Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
    Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart Drug Delivery Systems in Cancer Therapy.
    Unsoy G; Gunduz U
    Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trigger responsive polymeric nanocarriers for cancer therapy.
    Kaur S; Prasad C; Balakrishnan B; Banerjee R
    Biomater Sci; 2015 Jul; 3(7):955-87. PubMed ID: 26221933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.
    Zhou Q; Zhang L; Yang T; Wu H
    Int J Nanomedicine; 2018; 13():2921-2942. PubMed ID: 29849457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimuli-responsive liposomes for drug delivery.
    Lee Y; Thompson DH
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.